| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | May 13, 2024 | Sale | $1.26 | 34,840 | 43,898 | 672,092 | May 14, 2024, 04:04 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Feb 29, 2024 | Sale | $1.58 | 8,661 | 13,684 | 706,932 | Mar 01, 2024, 05:49 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Feb 27, 2024 | Sale | $1.52 | 10,744 | 16,331 | 715,593 | Feb 29, 2024, 06:02 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | May 25, 2023 | Sale | $1.22 | 95,478 | 116,760 | 574,037 | May 25, 2023, 09:01 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Mar 01, 2023 | Sale | $0.88 | 20,412 | 17,912 | 281,869 | Mar 03, 2023, 08:01 AM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Feb 28, 2022 | Sale | $2.15 | 6,555 | 14,125 | 258,995 | Mar 02, 2022, 09:11 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Mar 01, 2022 | Sale | $2.17 | 14,978 | 32,513 | 302,122 | Mar 02, 2022, 09:11 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Apr 01, 2021 | Sale | $3.40 | 1,211 | 4,117 | 265,550 | Apr 01, 2021, 08:33 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Mar 01, 2021 | Sale | $3.40 | 14,547 | 49,403 | 263,058 | Mar 02, 2021, 04:08 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | Feb 28, 2020 | Sale | $8.70 | 6,972 | 60,656 | 204,960 | Mar 02, 2020, 07:29 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Apr 11, 2019 | Option Exercise | $7.70 | 11,909 | 91,699 | 146,932 | Apr 12, 2019, 04:01 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Dec 12, 2018 | Option Exercise | $8.94 | 23,385 | 209,062 | 93,841 | Dec 13, 2018, 08:14 AM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Oct 02, 2017 | Sale | $19.64 | 1,398 | 27,457 | 95,826 | Oct 04, 2017, 04:20 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Sep 28, 2017 | Sale | $19.30 | 5,000 | 96,500 | 97,224 | Oct 02, 2017, 04:04 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Aug 15, 2017 | Sale | $15.00 | 5,000 | 75,000 | 102,224 | Aug 17, 2017, 04:06 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Jul 03, 2017 | Sale | $14.26 | 1,399 | 19,947 | 107,224 | Jul 06, 2017, 12:25 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Apr 03, 2017 | Sale | $9.18 | 1,401 | 12,858 | 108,623 | Apr 04, 2017, 04:01 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Jan 01, 2017 | Sale | $10.49 | 1,629 | 17,089 | 70,524 | Jan 03, 2017, 04:02 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Oct 01, 2016 | Sale | $8.95 | 1,401 | 12,546 | 72,153 | Oct 04, 2016, 04:12 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Jul 05, 2016 | Sale | $7.47 | 1,402 | 10,468 | 73,554 | Jul 06, 2016, 04:08 PM | |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Business Officer | Apr 04, 2016 | Sale | $9.41 | 1,401 | 13,183 | 74,956 | Apr 05, 2016, 04:01 PM |
Menu